Bo Netterstrøm1, Lene Friebel, Yun Ladegaard. 1. Department of Occupational and Environmental Medicine, Bispebjerg University Hospital, Copenhagen, Denmark. bnet0002@bbh.regionh.dk
Abstract
BACKGROUND: To evaluate the efficacy of a multidisciplinary stress treatment programme. METHODS:General practitioners referred 198 employed patients on sick leave with symptoms of persistent work-related stress. Using a waitlisted randomised controlled trial design, the participants were randomly divided into the following three groups: the intervention group (IG, 69 participants); treatment-as-usual control group (TAUCG, 71 participants), which received 12 consultations with a psychologist, and the waitlisted control group (WLCG, 58 participants). The stress treatment intervention consisted of nine 1-hour sessions conducted over 3 months. The goals of the sessions were the following: (1) identifying relevant stressors; (2) changing the participant's coping strategies; (3) adjusting the participant's workload and tasks, and (4) improving workplace dialogue. Each participant also attended a mindfulness-based stress reduction (MBSR) course for 2 h a week over 8 weeks. RESULTS: The IG and TAUCG showed significantly greater symptom level (Symptom Check List 92) reductions compared to the WLCG. Regarding the return to work (RTW) rate, 67% of participants in the IG returned to full-time work after treatment, which was a significantly higher rate than in the TAUCG (36%) and WLCG (24%). Significantly more participants in the IG (97%) increased their working hours during treatment compared with the participants in the control groups, TAUCG (71%) and WLCG (64%). CONCLUSIONS: The stress treatment programme--a combination of work place-focused psychotherapy and MBSR--significantly reduced stress symptom levels and increased RTW rates compared with the WLCG and TAUCG.
RCT Entities:
BACKGROUND: To evaluate the efficacy of a multidisciplinary stress treatment programme. METHODS: General practitioners referred 198 employed patients on sick leave with symptoms of persistent work-related stress. Using a waitlisted randomised controlled trial design, the participants were randomly divided into the following three groups: the intervention group (IG, 69 participants); treatment-as-usual control group (TAUCG, 71 participants), which received 12 consultations with a psychologist, and the waitlisted control group (WLCG, 58 participants). The stress treatment intervention consisted of nine 1-hour sessions conducted over 3 months. The goals of the sessions were the following: (1) identifying relevant stressors; (2) changing the participant's coping strategies; (3) adjusting the participant's workload and tasks, and (4) improving workplace dialogue. Each participant also attended a mindfulness-based stress reduction (MBSR) course for 2 h a week over 8 weeks. RESULTS: The IG and TAUCG showed significantly greater symptom level (Symptom Check List 92) reductions compared to the WLCG. Regarding the return to work (RTW) rate, 67% of participants in the IG returned to full-time work after treatment, which was a significantly higher rate than in the TAUCG (36%) and WLCG (24%). Significantly more participants in the IG (97%) increased their working hours during treatment compared with the participants in the control groups, TAUCG (71%) and WLCG (64%). CONCLUSIONS: The stress treatment programme--a combination of work place-focused psychotherapy and MBSR--significantly reduced stress symptom levels and increased RTW rates compared with the WLCG and TAUCG.
Authors: Nicole Vogel; Stefan Schandelmaier; Thomas Zumbrunn; Shanil Ebrahim; Wout El de Boer; Jason W Busse; Regina Kunz Journal: Cochrane Database Syst Rev Date: 2017-03-30
Authors: Lynn P Clemow; Thomas G Pickering; Karina W Davidson; Joseph E Schwartz; Virginia P Williams; Jonathan A Shaffer; Redford B Williams; William Gerin Journal: Transl Behav Med Date: 2018-09-08 Impact factor: 3.046
Authors: Myrthe van Vilsteren; Sandra H van Oostrom; Henrica C W de Vet; Renée-Louise Franche; Cécile R L Boot; Johannes R Anema Journal: Cochrane Database Syst Rev Date: 2015-10-05
Authors: Kenneth Jay; Mikkel Brandt; Emil Sundstrup; Mc Schraefel; Markus D Jakobsen; Gisela Sjøgaard; Lars L Andersen Journal: BMC Musculoskelet Disord Date: 2014-12-18 Impact factor: 2.362
Authors: Vita Ligaya Dalgaard; Lars Peter Sønderbo Andersen; Johan Hviid Andersen; Morten Vejs Willert; Ole Carstensen; David John Glasscock Journal: J Negat Results Biomed Date: 2017-08-22
Authors: Pernille Pedersen; Hans Jørgen Søgaard; Merete Labriola; Ellen A Nohr; Chris Jensen Journal: BMC Public Health Date: 2015-08-08 Impact factor: 3.295
Authors: Didier Allexandre; Adam M Bernstein; Esteban Walker; Jennifer Hunter; Michael F Roizen; Thomas J Morledge Journal: J Occup Environ Med Date: 2016-03 Impact factor: 2.162